These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 36505475)
21. Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 Structural Proteins and their Potential Cross-reactivity with Emerging Variants and other Human Coronaviruses. Pacheco-Olvera DL; Saint Remy-Hernández S; García-Valeriano MG; Rivera-Hernández T; López-Macías C Arch Med Res; 2022 Nov; 53(7):694-710. PubMed ID: 36336501 [TBL] [Abstract][Full Text] [Related]
22. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine. Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination. Graninger M; Camp JV; Aberle SW; Traugott MT; Hoepler W; Puchhammer-Stöckl E; Weseslindtner L; Zoufaly A; Aberle JH; Stiasny K Front Immunol; 2022; 13():888794. PubMed ID: 35711424 [TBL] [Abstract][Full Text] [Related]
24. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination. Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434 [TBL] [Abstract][Full Text] [Related]
25. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Nguyen TTN; Choo EM; Nakamura Y; Suzuki R; Shiina T; Shin-I T; Fukuta M; Nguyen CT; Nguyen TTT; Nguyen LKH; Hoang VMP; Morita K; Dang DA; Hasebe F; Le TQM; Moi ML Int J Infect Dis; 2024 Feb; 139():109-117. PubMed ID: 37984763 [TBL] [Abstract][Full Text] [Related]
26. Cross-protection induced by highly conserved human B, CD4 Prakash S; Dhanushkodi NR; Zayou L; Ibraim IC; Quadiri A; Coulon PG; Tifrea DF; Suzer B; Shaik AM; Chilukuri A; Edwards RA; Singer M; Vahed H; Nesburn AB; Kuppermann BD; Ulmer JB; Gil D; Jones TM; BenMohamed L Front Immunol; 2024; 15():1328905. PubMed ID: 38318166 [TBL] [Abstract][Full Text] [Related]
27. Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies. Ling Z; Yi C; Sun X; Yang Z; Sun B Sci China Life Sci; 2023 Apr; 66(4):658-678. PubMed ID: 36443513 [TBL] [Abstract][Full Text] [Related]
28. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants. Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733 [TBL] [Abstract][Full Text] [Related]
29. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287 [TBL] [Abstract][Full Text] [Related]
30. Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development. Magazine N; Zhang T; Bungwon AD; McGee MC; Wu Y; Veggiani G; Huang W Immunohorizons; 2024 Mar; 8(3):214-226. PubMed ID: 38427047 [TBL] [Abstract][Full Text] [Related]
31. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668 [TBL] [Abstract][Full Text] [Related]
32. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection. Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684 [TBL] [Abstract][Full Text] [Related]
33. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. Mittal A; Khattri A; Verma V PLoS Pathog; 2022 Feb; 18(2):e1010260. PubMed ID: 35176090 [TBL] [Abstract][Full Text] [Related]
34. Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents. Yan Q; Zhang Y; Hou R; Pan W; Liang H; Gao X; Deng W; Huang X; Qu L; Tang C; He P; Liu B; Wang Q; Zhao X; Lin Z; Chen Z; Li P; Han J; Xiong X; Zhao J; Li S; Niu X; Chen L Emerg Microbes Infect; 2024 Dec; 13(1):2290841. PubMed ID: 38044868 [TBL] [Abstract][Full Text] [Related]